A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published ...
An international team led by the ITACA Institute at the Universitat Politècnica de València (UPV) has developed one of the ...
Oryon Cell Therapies emerged from stealth on Monday with $21 million in new funding and early clinical data showing signs ...
A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss. In ...
Analysis of clinical and imaging data reveals rest tremor in Parkinson’s is not tied to greater dopamine loss, but instead to ...
A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss.
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that ...
Precision brain imaging of individuals with Parkinson’s disease reveals that the affected circuit is best characterized as a previously described network of brain regions called the somato-cognitive ...
A clinical imaging study from Finland suggests that rest tremor in Parkinson’s disease is not caused by greater dopamine loss ...
Simple food choices may slow brain aging and protect memory over time. The MIND diet could help keep your brain healthier as ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) announced that it will open its first US brain-dedicated positron emission ...
Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results